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Levels of TNF-a in Petients with Congestive
Hesrt Fsilure
N.Galib,F.Grfgioni,V.Cetvi,S.Boschi,L.Uguccioni,G.Ussia,
P.Cafanzariti,A. Fucili,A. Branzi,B. Magnani.Instituteof Cardiology,
Universityof Bologna,Italy
The citokinetumor necrosisfactor-a(TNF-a)has bean impliestsdin the
pethogeneaiaof chronicheartfailure(CHF)aswellas in acuteandchronic
hearttransplantrejection.Thetime courseof plasmalevelsof TNF-awas
aaaesaadin 19 patientswith CHF(age54 + 7 years)beforehearttrans-
plantation(b-HTx)and 3, 6 and 12 monthsaftersurgery(HTx-3,-6, -12).
Bloodwas withdrawnfrom the antacubitelvein and a myocsrdialbiopsy
wasperformedwithin12 hours.TNF-czplasmalevelswereassessedalso
in 10age-matchedcontrolsubjects.Analysiswasperformedbya sandwitch
ELISAmethod.Statisti@were performedby ANOVA.The TNF-aplasma
Ievela(p@ml)wereasfollows:
Controls b-HTx HTX-3 HTX-6 HTX-12
6.74=3.3 28.1+ 10.7* 23.1+ 10,6* 23.2& 12.4’ 23+ 11.5*
ANOVA:p <0.0001.*p c 0.05vsControls.
In 5 myocardialbiopsiesof 5 differentpatientsa multifocalmoderate
rejection(grade3A or B of BillinghamScale)was deteetsd.The TNF-a
plasmalevelsin caseof grade3 rejectionwereincreasedwhencompared
to the levelsobservedin caaeof mild(grade1Aor B)andnorejeetion(40l
10.8VS20.7+ 8.9pg/ml,p < 0.05)andwhencomparedtotheb-HTxvalues
(p < 0.05).Nodifference wereobservedbetweenTNF-aplasmalevelsin
caseof no rejectioncomparedto grade1Aor B acuterejection(21.7+ 8.6
vs 19.5* 9.5pg/ml,ns).
Conclusion:1)theelevatedplasmalevelsofTNF-aofpatientswithCHF
tendtodscreaaeafferHTxinabsenceofmultifocalmoderaterejection(grade
3Aor B)buttheyremainelevatedcomparedto the plasmalevelsof control
subjecfa;2) TNF-aplasmalevelsincreasemarkedlyin caseof grade3Aor
Bacuterejeefionalsoin comparisonto theb-HTxlevels.
11086-175/ Reeppraisalofthe Prscticeof Performing
Surveillance Endomyocardisl Biopsies After
Heart Transplantation: Decreased Utility for
Clinicsl Decision Msking Over Time
J.J. Kim,S. McRee,G.Thomas,J. Farmer,G.Terra-Amione.Baylor
CollegeofMadicineandTheMethodistHospital,Houston,TX,USA
Endomyocerdialbiopsies(EMBa)in hearttransplantrecipientsareroutinely
performedin anattemptto detectsubclinicalepisodesof rejection.Bsesuse
episodesof rejectionoccurmorefrequentlyesrfyaftertransplantationand
thendecreasewithtime,it is unclearwhetherperformingsurveillanceEMBs
> 1 year post transplantationalters therapy.To investigatethe effectof
surveillanceEMBsonchangesin immunosuppressiontherapy,wereviewed
the resultaof 1949 EMBsperformedin 134consecutivehearttransplant
patientsbetween1989-1996.We performed1357 EMBs< 1 year post
transplantand592 in all subsequentyears.Histologicalscoresof rejection
that resultedin changesin therapyoccurredin 210of 1357(15.5%)EMBs
performedc 1 year,whereasOnly in 16 of 592 EMBs(2.7%)performed>
1 year,p <0.001. Furthermore,in the groupof EMBaperformed>1 year,
clinicallydrivenEMBereeultsdin higherdiagnosticyieldandconaaquently
morechangesintherspymmpsrsdto EMBsobtainedforsurveillance(W146
vs6/448respectively,p < 0.001).WeconcludethatsurveillanceEMBsper-
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formed <1 yearbutnotthereafterresultin frequentremgnitionof rejection
episodesand consequentlychangesin immunosuppresaivetherapy,Our
data demonstratethat the utilityof obtainingsurveillanceEMBsfor clini-
cal decisionmakingdecreasesovertime and suggestthat > 1 year post
transplantonlyclinicallydrivenEMBsshouldbepetformed.
m1086176 Identification of Patients not Raquiring
Endomyocardial Biopsies Lete after Cardiac
Transphntstion - ,
H.P.Brunner-LaRocca,W.Kiowski.Divisionof Card/o/og~University
Hospital,Zurich,Switzerland
Theriskforcardiacallogreftrejectionishighestearlyaffertransplantation(fx)
butgraftrejectionrequiringintensifiedimmunoauppression(Rej)mayoccur
lateaftertx. Yet,manypatients(pts)are absolutelyfree of Rej.Therefore,
we triadto identitypts lateafter tx who maynot needfurthersurveillance
endomyocardialbiopsies(EMB).in 112 pts (age 46 + 12 year+ with a
follow-upof z 3 years,a totalof4194EMBwereperformed.Ofthese,1364
wereperformedafterthe 2ndpost-txyear.EMBweredividedinto3 groups
accordingto theseverityof graftrejection:Rejectionscore(Rs)= O:ISHTO
or 1AorTexas*2; Rs= 1: ISHTIB or 2 or Texas3-4; Rs=2: ISHTz 3A
orTexasz 5. Whenconsideringall EMBz 2 yearsaftertx,sumof Ra(OR=
1.05perscorepoint),meancyclosporinelevelin thefirst2 yeare(cycle;OR
= 1.05perpercentof uppertherapeuticrange),age (OR= 0.96 paryear),
timeaftertx(OR=0.75peryear),cyclosporinelevelbelowtherapeuticrange
(OR= 1.75),and reductionof prsdnisone(OR= 1.97)were independent
predictorsof Rej(allp < 0.05).31 of 112(28%)ptshadat leastonefurther
Rej(mean1.7)afterthe”2ndpaat-txyear.Independentpredictorsidentifying
ptswithRejwerethesumof Rs(OR= 1.07),cycle(OR= 1.07),as wellas
recipientage(OR=0.96;allp < 0.05).Rss 17,age? 25yeara,andcyclos
90fhpercentileidentified52%of ptswhowouldnothaveneededEMBafter
the 2ndpost-fxyearwhereasthe other48% had a riskof 54%to develop
furtherRej.Cone/uaion.’Riskof Rejremainsconsiderablyhigh in somepts
evenlateafter&justifyingfurtherEMB.HoweverRs,cycloaftertx,andage
accuratelyidentify52%pts in whomEMBare no longernsceasaryas long
aaimmunosuppressivetherapyremainsunchanged.
11086-177I ACcWacy0f8erumTroPonin TForPredkXing
Acute Cellular Rejection In OrthotropicHeart
Transplant Recipients
E.A.Caracciolo,T.J.Martin,J.A.Jones,T.L.Wolford,C.J.Mechem,
T.J.Donohue.SaintLouisUnivarsifyHaa/thSciancesCentecSt.Louis,
MO,USA
Allograffrejectionia a leadingcauaeof morbidityand mortalityfollowing
orfhotopichearttrensplantion.Rightventricularendomyocerdialbiopayis
thegoldstandardfordiagnosisof acutecellularrejection.Noninvasiveteat-
ing and serummarkershavebeenof limitedutility in pradietingrejaefion.
Thepresenceof Troponin-Tin the serumiaan accuratemarkerof myocyte
damagein patientswithiechemicsyndromea,but hasunknownclinicalutil-
ikyfor detectingrajsefion.Thisatudysoughtto determinethe accuracyof
Tro~nin-T to predicthigh-gradebiopsyprovencellularrejectionin trans-
plantrecipients.65consecutivepatientsunderwent127biopsies1 weekto
8 yearsaftertransplant.Bleedwas obtainedfrom the sheathprior to the
biopsy.A monoelonalantibodyassaywasusedformeasuringserumcardiac
Troponin-Tlevels.Valuesz 0.1ng/mLwereconaidersdabnormal.Standard
ISHLThistologiccriteriawereusedto gradethe biopaysampiea.Rejection
episodesweredefinedas:low-grade(S grade2); high-grade(~ 3A).
AllPatients >6 Monthsposttrsnsplsnt
(n= 127biopsies) (n= 65biopsies)
Sensitivity 50% 500/n
Spaeificity 60% 86”/6
Positiveprsdictivevalue 32% 27%
Negativepradictivsvslue 90% 94%
Despitea lowsensitivity,serumTroponin-Tvaluesc 0.1 ng/dLprovide
an accuratenon-invasivemarkerfor identifyingpatientswithouthigh-grade
rejection.
w] pharmacOkinetic, BIOodPreasure, and Renal
Effects of Cyclosporine Sandimmune Vs Neoral
Formulation in Heart Transplant Recipients
M.White,G.B.Pelietier,C.Jeaina,M.Carrier.Montrea/Haarthrsfitute,
Montreal,Quebec,Canada
SandimmuneNsoral(C-NOO)is a newformulationof cyclosporineA (cycle)
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which has a betterandamore predictable phamacokinetic than Sandimmune
(Sand) in renal and liver transplant recipients. The tolerability, pharmamki-
netic, and the effect of C-Neo on 24-hour blood preasure, renal function and
biochemistry profile have been incompletely studied in heart transplant re-
cipient. Twenty heart transplant recipients aged 54+ 9 years (mean+ SD)
were studied 5.2 + 2 years after tranaplantation in an open-label single arm
conversion protocol. Twelve-hour pharmacokinetic studies, renal function,
biochemistry profile and 24-hour ambulatory blood pressure monitoring were
completed on Sand and after 4 weeks of therapy with C-Neo. A 6-month
follow-up with serial clinical visits and bicehemiatry profile was completed.
Conversion to C-NSOresulted in a 32% increase in peak CYCIOconcentration
(Tmex) and a 24% increase in the area-under-the-curve without significant
changes in CYCIOtrough levels. Twenty-four-hour blood pressure, renal func-
tion, and lipid profile did not change aignificsntly after6 monthe of treatment
with C-NOO.The nocturnal drop in systolic blood preasurewas attenuated by
C-NSO[-4& 0.3Y0(Sand) p -=0.05 vs -2 + 0.3% (C-NSO)NS] and hyper-
tension worsens in 20% of patients (3/15) previously known as hypertensive.
Serum magnesium decreased significantly at 6 months [0.81 * 0.10 (Sand)
va 0.86 A 0.06 mmol/L (C-Neo) p c 0.01] despite similar cyclo trough levels.
Thus, for similar dosages, exposure to cyclo is increased by 24% on C-NSO
in stable heart trsnaplant recipients. This slightly increases blood pressure
and decressea magnesium levels. The enhanced drug exposure by C-NSO
haa the potential to maintain a steroid-free regimen and a dose decreaae.
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m1087166 TheClinicalUtilityofAutomaticBorderDetectioninthaAasaaamantofMyocardial
Iachemiain PediatricPatiantaDuring
DobutamineStreaaTeating
S.A.,Witt, R.E. Kardon, P.R. Khoury, T.R. Kimball. NoninvasiveCardiac
ImagingandHemodynamicResearchLaboratow,Divisionof Cardiology
Children’sHospitalMedicalCentecCincinnati,OH,USA
We hypothesized that abnormal left ventricular filling patternsduringdobu-
tamine streas testing (DST) may bean indicative of isohemia in children, as
in adults. However, Doppler indices are heart-rate dependent at hearl rates
encountered during pediatric DST. Previously we have reported that auto-
mated border detection (ABD) diastolic indices are heart rate independent.
To evaluate the potential of ABD in the assessment of diastolic function in
children with and without myocsrdal isohemia, ABD was performed in 22
children (1 mos-17, yrs) at rest and during DST. Six patients had ischemia
(wall motion abnormalities on DST). Sixteen patients had no evidence of ia-
chemia. Diastolic function was asaesaadby ABD LV peak filling rate (PFR) at
rest and at peak dobutamine doae. Resu/ts.’At rest, LV PFR was significantly
lower in the ischemicpetientsvs non-ieohemicpatients. At peak dobutamine,
this difference became even more marked.
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We conclude that ABD assessment of left ventricular filling patterns in
patients at rest and during dobutsmirw atresa testing detects diastolic dys-
function, thereby facilitating the diagrrosiaof ischemia.
function in normal (NL) human fetusas compared to fetuses with congenital
heart disease (CHD). Methods: This iaaretroapective analyaiaof prerecorded
fetal echocardiogrsms from 33 fetuses with CHD and 33 NLfetusea matched
for maternal age and race and fetal gestational age and sex. CHD fetusea
had a variely of heart lesions, including VSD (13), AA! canal (5), tetralcgy of
Fallot (4), DORV (4), and others (7). Extracardiac anomalies were present
in 9%. LV and RV systolic and diastolic area (A), length (L), and volume
(V) were measured using mono and bi-plane Simpaon’a rule. LV and RV
stroke volume (SV), cardiac output, and volume and area EF (AEFand VEF)
were calculated from systolic and diastolic volumes and hearl rate. Analysis
was by paired t-test. Resu/ts: Intraobserver and beat-to-beat variability of
RV and LV systolic and diastolic length and area averaged approximately
6%. LV volumes measures from monoplane four chamber views were not
statistically different from monoplane with chamber or biplane Simpson’s rule
volumes. Heart rates were not different between NL and CHD fetuaes at
any gestational age. LV and RV end diastolic volumes were not significantly
different between NLand CHDfetuses (p c 0.6). LVand RVsystolicvolumes
were significantly increased in CHD fetuses by 31% (p c 0.01) and 28°A (p
< 0.02), respectively.This represents a mean decrease in LV and RV stroke
VOlUm8 of 0.49 ml (31%, p < 0.04) and 0.46 ml (28%, p < 0.01), respectively.
LV and RV area and volume EF’s were similarly decreased in CHD fetuses
compared to NL matched controls (see Table).
VentricularEjectionFractionin NL and CHD Fetuses (*P < 0.0001)
LVAEF(%) RVAEF (O/.) LWEF (4A) RVVEF (0/’)
NL 5S.3 & 8 59.4 * 5 74.7 * s 73.0 * 7
CHD 37.9 l 8* 39.9 +9* 51.6 +6* 50.5 * 10”
Conclusion:Right and LV systolic function ia decreased in fetusea with
CHD compared to matched normal fetuses. This amount of ventricular dys-
function could produce significant hemodynamic compromise in CHD fa-
tuses.
11087-I68I ANabVNon-hlvasivaMethOdtODetermine
CombinedSyatolicandDiaatolicVentricular
Function:EvaluationinNormalChildrenand
DilatadCardiomyopathy
M. Lewin, R. Pignatelli, L. Bezold, D. Cates, N. Ayres, R. Gajarski. Texas
Chi/dren’sHospital,Efay/orCo//egeof Medicine,I-fouaton,TX,USA
A Doppler index of combined systolic and diastolic ventricular function in
adults has recently been described (TEl Index). In the pediatric population a
simple, reproducible and non-invasive test of global ventricular dysfunction
would beauseful diagnoaticadjunct. Twenty six pediatric controls with normal
echocardiograms were compared to 30 children with dilated cardiomyopa-
thy (oCM), aa determinedby echocardiography and cardiac catheterization.
Echocardiogramswere retrospectively reviewed andthe TEl Index meaaured
(Osovolumiccontrectiontime (lCT) + iaovolumic relaxation time (IRT))~ ejec.
tion time (ET)).Thia index was also calculated with the ETcorraoted for heart
rate (HR). The pm-ejection period (PEP)+ ET,and the ejection fraction (EF)
were measured for comparison. Compared to controls, DCM left ventricular
(LV)TEI Index (0.77 vs 0.27; p < 0.001), end DCM right ventricular (RV) TEI
Index (0.64 vs 0.07; p c 0.001) were significantly increased. Similarly, when
compared to controls, the DCM HR-correcfed LV TEi Index (0.33 va 0.02; p
< 0.001) and RV TEI Index (0.26vs –0.13; p < 0.005) remained significantly
higher. LV TEI Index correlated well with EF, and LV and RV TEI Indices
correlated with PEP + ET.
TricuspidFlow
Aordc/PrdmooaryFlow
When compared to controls, the TEl Index iagreater inpediatric patients with
combined systolic and diastolic dysfunction, and correlates well with usual
indicators of ventricular dysfunction. The TEI Index can be used to aaaesa
both LV and RV function; in children HR correction is not required.
1087-167 BiventricularDysfunctionin Fatusaawith
CongenitalHeartDiaeasa
W.A. Lutin, C.E. Tharpe, F.M. McGaffrey.Medical College of Georgia,
Augusta,GA,USA,Universityof Kentucky,Lexington,KentuckyUSA
Purpose:We have shown that left ventricular (LV) ejection fraction (EF) is
decreased in chick embryoa with conotruncal hearl lesions, compared to
normal embryoa. The purpose of this study was to evaluate RV and LV
11087-1691 Durationof PulmonaryVenouaAtrialReveraal&
MitralA WavaCanPredictElavatedEnd
DiastolicPreaaurain Children
K. Durongpisitkul, P.W.O’Lea~, K.R. Bailey, D.J. Hagler, J.B. Seward.
MayoClinic,RocheatecMN,USA
Recently the relationships between mitral inflow & pulmonary venous flow
patferns have been successfully applied to diastolic assessment in adults.
Todeterminethese relationships in children, we performed echocardiograma
